title: Stevens-Johnson syndrome in childhood.
abstract: BACKGROUND
  Stevens-Johnson syndrome and toxic epidermal necrolysis are two serious immune diseases within the context of bullous mucocutaneous syndrome. These have varying degrees of involvement of the skin and usually at least two mucous membranes.
  
  
  METHODS
  Three clinical cases are presented, two of them with significant ophthalmological sequelae, who had received drug treatment as a possible trigger, and another milder clinical case caused by Mycoplasma pneumoniae.
  
  
  CONCLUSIONS
  The ophthalmologist plays a crucial role in the outcome and eye care of the patient in order to try to avoid the appearance of sequelae and subsequent loss of vision.
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España. Electronic address: Nataliablancocalvo@gmail.com.
authors.forename: N
authors.initials: N
authors.lastname: Blanco
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: B
authors.initials: B
authors.lastname: Gutiérrez
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: I
authors.initials: I
authors.lastname: Valls
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: D
authors.initials: D
authors.lastname: Puertas
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: C
authors.initials: C
authors.lastname: Martín
authors.affiliation: Servicio de Oftalmología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: M
authors.initials: M
authors.lastname: Rivera
authors.affiliation: Servicio de Dermatología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: Á
authors.initials: Á
authors.lastname: Hernández
authors.affiliation: Servicio de Dermatología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Torrelo
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001684:Biological Dressings; D002648:Child; D003131:Combined Modality Therapy; D003231:Conjunctivitis / Q000209:etiology* / Q000628:therapy; D003318:Corneal Opacity / Q000209:etiology*; D003320:Corneal Ulcer / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D015352:Dry Eye Syndromes / Q000209:etiology* / Q000628:therapy; D004483:Ectropion / Q000209:etiology; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D011019:Pneumonia, Mycoplasma / Q000150:complications; D013262:Stevens-Johnson Syndrome / Q000150:complications* / Q000188:drug therapy
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D007052:Ibuprofen
keywords: Bullous mucocutaneous syndrome; Membranas mucosas; Mucous membranes; Mycoplasma pneumonia; Mycoplasma pneumoniae; Necrólisis epidérmica tóxica; Stevens Johnson syndrome; Síndrome Stevens Johnson; Síndrome mucocutáneo ampolloso; Toxic epidermal necrolysis